Clinical features of silent corticotroph adenomas

被引:50
|
作者
Alahmadi, Hussein [1 ,2 ]
Lee, Daniel [2 ]
Wilson, Jefferson R. [2 ]
Hayhurst, Caroline [2 ]
Mete, Ozgur [3 ]
Gentili, Fred [2 ]
Asa, Sylvia L. [3 ]
Zadeh, Gelareh [2 ]
机构
[1] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
[2] Univ Toronto, Div Neurosurg, Univ Hlth Network, Toronto, ON, Canada
[3] Univ Toronto, Dept Pathol, Univ Hlth Network, Toronto, ON, Canada
关键词
Silent corticotroph adenoma; Non-functioning adenoma; Pituitary adenoma; Apoplexy; Recurrent tumors; NONFUNCTIONING PITUITARY-ADENOMAS; CUSHINGS-DISEASE; CELL ADENOMA; TUMORS; ACTH; GLAND;
D O I
10.1007/s00701-012-1378-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Silent corticotrph adenomas represent a distinct pathological subtype of non-functioning pituitary adenomas that are traditionally believed to carry a more aggressive biological behavior and higher potential for recurrence. We conducted a retrospective review of all silent corticotroph adenomas treated and followed at our institution over the last 10 years. We reviewed clinical, radiological and pathological features. The series was compared to a matched cohort of ACTH-negative, non-functioning adenomas to compare clinical, radiological and pathological features. Our results were compared to the literature. Twenty patients met our inclusion criteria. Fifty-six percent of the patients were females. Mean age was 51 years (range 24-78 years). Visual dysfunction was the most common clinical presentation (38 %). Thirteen percent of the cases presented with acromegaly secondary to double adenoma (silent corticotroph adenoma and growth hormone adenoma) and 13 % presented with pituitary tumor apoplexy. All the tumors were macroadenomas. Frank cavernous sinus invasion occurred in 31 % of the cases. The patients who presented with acromegaly did not achieve remission postoperatively. In the remaining patients, recurrence occurred in 14 % of the cases over a mean follow-up period of 41 months. Compared to non-functioning adenomas, silent corticotroph adenomas were more likely to bleed (p value 0.014) and have double adenoma (p value 0.047). There was no difference in recurrence rates between silent corticotroph adenomas and non-functioning adenomas (p value 0.647). These results suggest that silent corticotroph adenomas have some unique features compared to non-functioning adenomas. Within the limits of our follow-up duration and sample size and our review of the literature, we would recommend that the traditional view to manage all silent corticotroph adenomas with adjuvant radiation should be reconsidered. We suggest adopting an initially more conservative follow-up surveillance and delay of upfront radiation until there is clear evidence of tumor recurrence.
引用
收藏
页码:1493 / 1498
页数:6
相关论文
共 50 条
  • [21] Perioperative hypothalamic pituitary adrenal function in patients with silent corticotroph adenomas
    Cheres, Abdelle F.
    ElAsmar, Nadine
    Rajpal, Aman
    Selman, Warren R.
    Arafah, Baha M.
    PITUITARY, 2017, 20 (04) : 471 - 476
  • [22] INSITU HYBRIDIZATION ANALYSIS OF FUNCTIONING AND SILENT CORTICOTROPH ADENOMAS OF THE HUMAN PITUITARY
    LLOYD, RV
    JIN, L
    HORVATH, E
    KOVACS, K
    LABORATORY INVESTIGATION, 1989, 60 (01) : A55 - A55
  • [23] Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence
    Strickland, Ben A.
    Shahrestani, Shane
    Briggs, Robert G.
    Jackanich, Anna
    Tavakol, Sherwin
    Hurth, Kyle
    Shiroishi, Mark S.
    Liu, Chia-Shang J.
    Carmichael, John D.
    Weiss, Martin
    Zada, Gabriel
    JOURNAL OF NEUROSURGERY, 2021, 135 (06) : 1706 - 1713
  • [24] Cytologic features of canine melanotroph and corticotroph pituitary adenomas
    Furtado, Adriana P.
    Decourcey, Michelle
    Miller, Margaret A.
    Chen, Annie V.
    Martin, Linda G.
    Guess, Sarah C.
    Wardrop, K. Jane
    de Souza, Cleverson
    Owen, Tina J.
    VETERINARY CLINICAL PATHOLOGY, 2024, 53 (01) : 99 - 103
  • [25] Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas
    Cho, Hwa Young
    Cho, Sun Wook
    Kim, Sang Wan
    Shin, Chan Soo
    Park, Kyong Soo
    Kim, Seong Yeon
    CLINICAL ENDOCRINOLOGY, 2010, 72 (05) : 648 - 653
  • [26] Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas
    Cazabat, Laure
    Dupuy, Martin
    Boulin, Anne
    Bernier, Michele
    Baussart, Bertrand
    Foubert, Luc
    Raffin-Sanson, Marie-Laure
    Caron, Philippe
    Bertherat, Jerome
    Gaillard, Stephan
    CLINICAL ENDOCRINOLOGY, 2014, 81 (04) : 566 - 572
  • [27] The Role of Mediators of Cell Invasiveness, Motility, and Migration in the Pathogenesis of Silent Corticotroph Adenomas
    Mete, Ozgur
    Hayhurst, Caroline
    Alahmadi, Hussein
    Monsalves, Eric
    Gucer, Hasan
    Gentili, Fred
    Ezzat, Shereen
    Asa, Sylvia L.
    Zadeh, Gelareh
    ENDOCRINE PATHOLOGY, 2013, 24 (04) : 191 - 198
  • [28] Silent corticotroph adenomas:: Presentation of two cases that presented with pituitary apoplexy.
    Lagares, A
    González, P
    Miranda, P
    Cabrera, A
    Lobato, RD
    Ramos, A
    Ricoy, JR
    NEUROCIRUGIA, 2004, 15 (02): : 159 - 164
  • [29] Variation of ACTH and Pituitary Transcription Factor Immunohistochemical Staining in Silent Corticotroph Adenomas
    Wu, Angela
    Lopes, Maria Beatriz
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2019, 78 (06): : 561 - 561
  • [30] Silent Corticotroph Adenomas: Emory University Cohort and Comparison With ACTH-Negative Nonfunctioning Pituitary Adenomas
    Ioachimescu, Adriana G.
    Eiland, Leslie
    Chhabra, Vaninder S.
    Mastrogianakis, Gena M.
    Schniederjan, Matthew J.
    Brat, Daniel
    Pileggi, Anthony V.
    Oyesiku, Nelson M.
    NEUROSURGERY, 2012, 71 (02) : 296 - 303